Psyence Biomedical Ltd.Psyence Biomedical Ltd.Psyence Biomedical Ltd.

Psyence Biomedical Ltd.

No trades
See on Supercharts
Market capitalization
‪2.08 M‬USD
‪−51.16 M‬USD
0.00USD
‪554.43 K‬
Beta (1Y)
0.09
Employees (FY)
10
Change (1Y)
+7 +233.33%
Revenue / Employee (1Y)
0.00USD
Net income / Employee (1Y)
‪−5.12 M‬USD

About Psyence Biomedical Ltd.


CEO
Neil Maresky
Headquarters
Toronto
Founded
2021
FIGI
BBG01L71H227
Psyence Biomedical Ltd. is a life science biotechnology company. It develops natural psilocybin products for the healing of psychological trauma and its mental health consequences in the context of palliative care. The company was founded on February 25, 2021 and is headquartered in Toronto, Canada.
Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:
Summarizing what the indicators are suggesting.
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Displays a symbol's price movements over previous years to identify recurring trends.

Frequently Asked Questions


The current price of PBM is 3.18 USD — it has increased by 60.78% in the past 24 hours. Watch Psyence Biomedical Ltd. stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on NASDAQ exchange Psyence Biomedical Ltd. stocks are traded under the ticker PBM.
PBM stock has risen by 20.00% compared to the previous week, the month change is a −40.36% fall, over the last year Psyence Biomedical Ltd. has showed a −99.58% decrease.
PBM reached its all-time high on Nov 22, 2023 with the price of 1,091.25 USD, and its all-time low was 1.80 USD and was reached on Dec 9, 2024. View more price dynamics on PBM chart.
See other stocks reaching their highest and lowest prices.
PBM stock is 64.39% volatile and has beta coefficient of 0.09. Track Psyence Biomedical Ltd. stock price on the chart and check out the list of the most volatile stocks — is Psyence Biomedical Ltd. there?
Today Psyence Biomedical Ltd. has the market capitalization of ‪1.78 M‬, it has decreased by −15.46% over the last week.
Yes, you can track Psyence Biomedical Ltd. financials in yearly and quarterly reports right on TradingView.
No, PBM doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Dec 21, 2024, the company has 10.00 employees. See our rating of the largest employees — is Psyence Biomedical Ltd. on this list?
Like other stocks, PBM shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Psyence Biomedical Ltd. stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So Psyence Biomedical Ltd. technincal analysis shows the neutral today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating Psyence Biomedical Ltd. stock shows the sell signal. See more of Psyence Biomedical Ltd. technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.